Rentokil Initial (LON:RTO – Free Report) had its target price decreased by Citigroup from GBX 575 to GBX 550 in a research note issued to investors on Friday morning, Marketbeat reports. Citigroup currently has a buy rating on the stock.
RTO has been the subject of several other research reports. Royal Bank Of Canada reissued an “outperform” rating and issued a GBX 540 price objective on shares of Rentokil Initial in a research note on Friday, June 5th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 550 target price on shares of Rentokil Initial in a research note on Thursday, July 9th. Five equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Rentokil Initial has an average rating of “Moderate Buy” and an average target price of GBX 463.
Read Our Latest Research Report on Rentokil Initial
Rentokil Initial Stock Performance
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats.
Further Reading
- Five stocks we like better than Rentokil Initial
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
